BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10978264)

  • 41. Comparative studies on the inhibitory spectrum of recombinant hirudin, DuP 714 and heparin on thrombin and factor Xa generation in biochemically defined systems.
    Kaiser B; Callas D; Hoppensteadt D; Mallinowska K; Fareed J
    Thromb Res; 1994 Mar; 73(5):327-35. PubMed ID: 8016817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of thrombin inhibition with desulfatohirudin on early kinetics of cellular proliferation after balloon angioplasty in atherosclerotic rabbits.
    Ragosta M; Barry WL; Gimple LW; Gertz SD; McCoy KW; Stouffer GA; McNamara CA; Powers ER; Owens GK; Sarembock IJ
    Circulation; 1996 Mar; 93(6):1194-200. PubMed ID: 8653841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radioimmunoassay for the detection of active-site specific thrombin inhibitors in biological fluids. II. Heparin affects the binding of hirudin to alpha-thrombin.
    Lackmann M; Geczy CL
    Thromb Res; 1991 Sep; 63(6):609-16. PubMed ID: 1780805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass model.
    Walenga JM; Bakhos M; Messmore HL; Koza M; Wallock M; Orfei E; Fareed J; Pifarre R
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):105-11. PubMed ID: 1772977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial.
    Fuchs J; Cannon CP
    Circulation; 1995 Aug; 92(4):727-33. PubMed ID: 7641350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of the hemostatic mechanism during thrombolysis in patients with unstable angina pectoris.
    Merlini PA; Ardissino D; Bauer KA; Oltrona L; Spinola A; Diotallevi P; Rosenberg RD; Mannucci PM
    Blood; 1995 Nov; 86(9):3327-32. PubMed ID: 7579435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes.
    Bahit MC; Topol EJ; Califf RM; Armstrong PW; Criger DA; Hasselblad V; Betriu A; Hirsh J; Ardissino D; Granger CB
    J Am Coll Cardiol; 2001 Mar; 37(4):1001-7. PubMed ID: 11263599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries.
    Gallo R; Padurean A; Toschi V; Bichler J; Fallon JT; Chesebro JH; Fuster V; Badimon JJ
    Circulation; 1998 Feb; 97(6):581-8. PubMed ID: 9494029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis.
    Heras M; Chesebro JH; Webster MW; Mruk JS; Grill DE; Penny WJ; Bowie EJ; Badimon L; Fuster V
    Circulation; 1990 Oct; 82(4):1476-84. PubMed ID: 2401076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudin.
    Bode C; Hudelmayer M; Mehwald P; Bauer S; Freitag M; von Hodenberg E; Newell JB; Kübler W; Haber E; Runge MS
    Circulation; 1994 Oct; 90(4):1956-63. PubMed ID: 7923685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma.
    Lindhout T; Blezer R; Hemker HC
    Thromb Haemost; 1990 Nov; 64(3):464-8. PubMed ID: 2096492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of heparin-resistant microarterial thrombosis by recombinant hirudin: a specific thrombin inhibitor.
    Arnljots B; Bergqvist D
    Plast Reconstr Surg; 1995 Apr; 95(5):894-900. PubMed ID: 7708874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of thrombin attenuates stenosis after arterial injury in minipigs.
    Abendschein DR; Recchia D; Meng YY; Oltrona L; Wickline SA; Eisenberg PR
    J Am Coll Cardiol; 1996 Dec; 28(7):1849-55. PubMed ID: 8962575
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery disease.
    Cannon CP; Maraganore JM; Loscalzo J; McAllister A; Eddings K; George D; Selwyn AP; Adelman B; Fox I; Braunwald E
    Am J Cardiol; 1993 Apr; 71(10):778-82. PubMed ID: 8456753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma.
    Gallistl S; Muntean W; Leis HJ
    Thromb Haemost; 1995 Oct; 74(4):1163-8. PubMed ID: 8560429
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction.
    French JK; Edmond JJ; Gao W; White HD; Eikelboom JW
    Am J Cardiovasc Drugs; 2004; 4(2):107-15. PubMed ID: 15049722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Higher concentrations of heparin and hirudin are required to inhibit thrombin generation in tissue factor-activated cord plasma than in adult plasma.
    Baier K; Cvirn G; Fritsch P; Köstenberger M; Gallistl S; Leschnik B; Muntean W
    Pediatr Res; 2005 May; 57(5 Pt 1):685-9. PubMed ID: 15718352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of recombinant hirudin and unfractionated heparin on thrombin and factor Xa generation in extrinsic and intrinsic activated systems.
    Kaiser B; Fareed J; Hoppensteadt D; Birdsong B; Walenga JM; Markwardt F
    Thromb Res; 1992 Jan; 65(2):157-64. PubMed ID: 1579892
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation: a pilot study. Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators.
    Circulation; 1997 Aug; 96(3):769-77. PubMed ID: 9264481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.